✦ LIBER ✦

New dosing strategies for liposomal amphotericin B in high-risk patients

✍ Scribed by Michael Ellis

Book ID: 111109305
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 237 KB
Volume: 14
Category: Article
ISSN: 1198-743X
DOI: 10.1111/j.1469-0691.2008.01982.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single-Dose Liposomal Amphotericin B for

Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India

✍ Sundar, Shyam; Chakravarty, Jaya; Agarwal, Dipti; Rai, Madhukar; Murray, Henry W 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 222 KB

High-Dose Liposomal Amphotericin B in th

High-Dose Liposomal Amphotericin B in the Therapy of Systemic Candidiasis in Neonates

✍ A. Juster-Reicher; O. Flidel-Rimon; M. Amitay; S. Even-Tov; E. Shinwell; E. Leib 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 129 KB

P980 Liposomal amphotericin B standard d

P980 Liposomal amphotericin B standard dose in combination with caspofungin versus liposomal amphotericin B high dose regimen for the treatment of invasive aspergillosis in immunocom-promised patients: randomised pilot study (Combistrat Trial)

✍ D. Caillot; A. Thiébaut; R. Herbrecht; A. Pigneux; S. de Botton; M. Attal; F. Be 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Antifungal therapy in thoracic cancer pa

Antifungal therapy in thoracic cancer patients with low dose liposomal amphotericin B (AmBisome)

✍ Cosimo Lequaglie; Gabriella Giudice; Pier Paolo Brega Massone; Ignazio Cataldo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 49 KB

High weekly doses of liposomal amphoteri

High weekly doses of liposomal amphotericin B as secondary prophylaxis after cerebral aspergillosis in a paediatric patient

✍ Brazzola, Pierluigi; Rossi, Mario R. 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 460 KB

Amphotericin B lipid complex versus lipo

Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy

✍ Ray Y. Hachem; Maha R. Boktour; Hend A. Hanna; Rola N. Husni; Harrys A. Torres; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) is a major cause of morbidity and mortality in patients with hematologic malignancy (HM). There are 2 lipid formulations of amphotericin B (AMB) currently in widespread use: AMB lipid complex (ABLC) and liposomal AMB (L‐AMB). There are limited